Aster DM Healthcare reported a strong second-quarter performance, with net profit climbing 13% year-on-year to Rs. 110 crore for the quarter ended September 30, 2025. The company’s consolidated revenue increased 10% to Rs. 1,197 crore, supported by steady operational growth and efficiency improvements across its hospital and pharmacy segments. Despite a softer season for illness-related admissions, Aster maintained profitability through disciplined cost management and strategic expansion.